{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:02:33Z","timestamp":1764997353044,"version":"3.40.4"},"reference-count":48,"publisher":"Colegio Mexicano de Inmunologia Clinica y Alergia, A. C.","issue":"4","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Alerg Mex"],"abstract":"<jats:p>The clinical manifestations of COVID-19 are reminiscent of those of acute respiratory distress syndrome induced by cytokine release syndrome and secondary hemophagocytic lymphohistiocytosis that is observed in patients with other coronaviruses such as SARS-CoV and MERS-CoV. Neurologists face the challenge of assessing patients with pre-existing neurological diseases who have contracted SARS-CoV-2, patients with COVID-19 who present neurological emergencies, and patients who are carriers of the virus and have developed secondary neurological complications, either during the course of the disease or after it. Some authors and recent literature reports suggest that the presence of neurological manifestations in patients who are carriers of SARS-CoV-2 may be associated with a greater severity of the disease. <\/jats:p>","DOI":"10.29262\/ram.v67i4.828","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T12:59:36Z","timestamp":1613134776000},"page":"338-349","source":"Crossref","is-referenced-by-count":5,"title":["La neurolog\u00eda de COVID-19","The neurology of COVID-19"],"prefix":"10.29262","volume":"67","author":[{"given":"Carlos","family":"Cuevas-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Calder\u00f3n-Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Berr\u00f3n-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11808","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"ref0","unstructured":"Organizaci\u00f3n Mundial de ls Salud [Internet]. Ginebra, Suiza: Brote de enfermedad por coronavirus (COVID-19). Disponible en: https:\/\/www.who.int\/es\/emergencies\/diseases\/novel-coronavirus"},{"key":"ref1","unstructured":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University & Medicine [Internet]. EE. UU.: Johns Hopkins University & Medicine; c2021. Disponible en: https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. DOI: 10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Majid F, Ali M, Somayeh M, Cyrus AR. Neurobiology of COVID-19. J Alzheimers Dis. 2020;76(1):3-19. DOI: 10.3233\/JAD-200581","DOI":"10.3233\/JAD-200581"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Machhi J, Herskovitz J, Senan AM, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;1-28. DOI: 10.1007\/s11481-020-09944-5","DOI":"10.1007\/s11481-020-09944-5"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Mohammadi S, Moosaie F, Aarabi MH. Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms. Mol Neurobiol. 2020;57(12):5263-5275. DOI: 10.1007\/s12035-020-02094-y","DOI":"10.1007\/s12035-020-02094-y"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27(5):1451-1454. DOI: 10.1038\/s41418-020-0530-3","DOI":"10.1038\/s41418-020-0530-3"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D. Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia. AJR Ame J Roentgenol. 2020;215(2):338-343. DOI: 10.2214\/AJR.20.22961","DOI":"10.2214\/AJR.20.22961"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Garc\u00eda LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11.1441. DOI: 10.3389\/fimmu.2020.01441","DOI":"10.3389\/fimmu.2020.01441"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Chong K, Mehta PR, Shukla G, Mehta AR. COVID-19, SARS and MERS: a neurological perspective. J Clin Neurosci. 2020;77:13-16. DOI: 10.1016\/j.jocn.2020.04.124","DOI":"10.1016\/j.jocn.2020.04.124"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Cheng Q, Yang Y, Gao J. Infectivity of human coronavirus in the brain. EBioMedicine. 2020;56:102799. DOI: 10.1016\/j.ebiom.2020.102799","DOI":"10.1016\/j.ebiom.2020.102799"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Li H, Xue Q, Xu X. Involvement of the nervous system in SARS-CoV-2 infection. Neurotox Res. 2020;38(1):1-7. DOI: 10.1007\/s12640-020-00219-8","DOI":"10.1007\/s12640-020-00219-8"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Kursat-Azkur A, Akdis M, Sokolowska M, van de Veen W, Br\u00fcggen C, O'Mahony L, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75(7):1564-1581. DOI: 10.1111\/all.14364","DOI":"10.1111\/all.14364"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Guihot A, Litvinova E, Autran B, Debr\u00e9 P, Vieillard V. Cell-mediated immune responses to COVID-19 infection. Front Immunol. 2020;11:1662. DOI: 10.3389\/fimmu.2020.01662","DOI":"10.3389\/fimmu.2020.01662"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kim SY, Kim DW. Does the clinical spectrum of coronavirus disease 2019 (COVID-19) show regional differences? Clin Exp Otorhinnolaryngol. 2020;13(2):83-84. DOI: 10.21053\/ceo.2020.00612","DOI":"10.21053\/ceo.2020.00612"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Abboud H, Abboud FZ, Kharbouch H, Arkha Y, Abbadi NE, Ouahabi AE. COVID-19 and SARS-CoV-2 infection: pathophysiology and clinical effects on the nervous system. World Neurosurg. 2020;140:49-53. DOI: 10.1016\/j.wneu.2020.05.193","DOI":"10.1016\/j.wneu.2020.05.193"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179-2184. DOI: 10.1007\/s00415-020-09929-7","DOI":"10.1007\/s00415-020-09929-7"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Fathi N, Rezaei N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int. 2020;44(9):1792-1797. DOI: 10.1002\/cbin.11403","DOI":"10.1002\/cbin.11403"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Koralnik IJ, Kenneth LT. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1-11. DOI: 10.1002\/ana.25807","DOI":"10.1002\/ana.25807"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413:116832. DOI: 10.1016\/j.jns.2020.116832","DOI":"10.1016\/j.jns.2020.116832"},{"key":"ref20","unstructured":"Brouwer MC, Ascione T, Pagliano P. Neurologic aspects of COVID-19: a concise review. Infez Med. 2020;28(Suppl 1):42-45. Disponible en: https:\/\/www.infezmed.it\/media\/journal\/Vol_28_suppl1_2020_7.pdf"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767-783. DOI: 10.1016\/S1474-4422(20)30221-0","DOI":"10.1016\/S1474-4422(20)30221-0"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Lechien JR, Chiesa-Estomba CM, de Siati DR, Horoi M, D Le Bon S, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-2261. DOI: 10.1007\/s00405-020-05965-1","DOI":"10.1007\/s00405-020-05965-1"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 2020;77(8):1028-1029. DOI: 10.1001\/jamaneurol.2020.2125","DOI":"10.1001\/jamaneurol.2020.2125"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, Quanwei H, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. DOI: 10.1001\/jamaneurol.2020.1127","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Tsai ST, Lu MK, San S, Tsai CH. The neurologic manifestations of coronavirus disease 2019 pandemic: a systemic review. Front Neurol. 2020;11:498. DOI: 10.3389\/fneur.2020.00498","DOI":"10.3389\/fneur.2020.00498"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Xiangming Meng, Yanzhong Deng, Zhiyong Dai, Zhisheng Meng. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. DOI: 10.1016\/j.amjoto.2020.102581","DOI":"10.1016\/j.amjoto.2020.102581"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Bolay H, G\u00fcl A, Baykan B. COVID-19 is a real headache! Headache. 2020:10.1111\/head.13856. DOI: 10.1111\/head.13856","DOI":"10.1111\/head.13856"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Yavarpour-Bali H, Ghasemi-Kasman M. Update on neurological manifestations of COVID-19. Life Sci. 2020;257:118063. DOI: 10.1016\/j.lfs.2020.118063","DOI":"10.1016\/j.lfs.2020.118063"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Correia AO, Feitosa PWG, Moreira JLDS, Nogueira S\u00c1R, Fonseca RB, Nobre MEP. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review. Neurol Psychiatry Brain Res. 2020;37:27-32. DOI: 10.1016\/j.npbr.2020.05.008","DOI":"10.1016\/j.npbr.2020.05.008"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Merkler A, Parikh N, Mir S, Gupta A. Risk of ischemic stroke in patients with coronavirus disease 20019 (COVID19) vs patients with Influenza. JAMA Neurol. 2020;77(11):1-7. DOI: 10.1001\/jamaneurol.2020.2730","DOI":"10.1001\/jamaneurol.2020.2730"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Ferrarese C, Silani V, Priori A, Galimberti S, Agostoni E, Monaco S, et al. An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID). Neurol Sci. 2020;41(6):1355-1359. DOI:10.1007\/s10072-020-04450-1","DOI":"10.1007\/s10072-020-04450-1"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Vacchiano V, Riguzzi P, Volpi L, Tappat\u00e0 M, Avoni P, Rizzo G, et al. Early neurological manifestations of hospitalized COVID-19 patients. Neurol Sci. 2020 Aug;41(8):2029-2031. DOI:10.1007\/s10072-020-04525-z","DOI":"10.1007\/s10072-020-04525-z"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020;417:117085. DOI: 10.1016\/j.jns.2020.117085","DOI":"10.1016\/j.jns.2020.117085"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Nepal G, Rehrig JH, Shrestha GS, Shing YK, Yadav JK, Ojha R, et al. Neurological manifestations of COVID-19: a systematic review. Crit Care. 2020;24(1):421. DOI: 10.1186\/s13054-020-03121-z","DOI":"10.1186\/s13054-020-03121-z"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Pinna P, Grewal P, Julianne P, Hall JP, Tavarez T, Dafer RM, et al. Neurological manifestations and COVID-19: experiences from a tertiary care center at the Frontline. J Neurol Sci. 2020;415:116969. DOI: 10.1016\/j.jns.2020.116969","DOI":"10.1016\/j.jns.2020.116969"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Wang L, Shen Y, Li M, Chuang H, Ye Y, Zhao H, et al. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol. 2020;267(10):2777-2789. DOI: 10.1007\/s00415-020-09974-2","DOI":"10.1007\/s00415-020-09974-2"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Lechien JR, Chiesa-Estomba CM, Place S, van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-344. DOI: 10.1111\/joim.13089","DOI":"10.1111\/joim.13089"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Romero-S\u00e1nchez CM, D\u00edaz-Maroto I, Fern\u00e1ndez-D\u00edaz E, S\u00e1nchez-Larsen \u00c1, Layos-Romero A, Garc\u00eda-Garc\u00eda J, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060-e1070. DOI: 10.1212\/WNL.0000000000009937","DOI":"10.1212\/WNL.0000000000009937"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Divani AA, Andalib S, di Napoli M, Lattanzi S, Shazam-Hussain M, Biller J, et al. Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebr Dis. 2020;29(8):104941. DOI: 10.1016\/j.jstrokecerebrovasdis.2020.104941","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104941"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis\/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55-58. DOI: 10.1016\/j.ijid.2020.03.062","DOI":"10.1016\/j.ijid.2020.03.062"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. 2020;296(2):E119-E120. DOI: 10.1148\/radiol.2020201187","DOI":"10.1148\/radiol.2020201187"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Krett J, Jewett GA, Elton-Lacasse C, Fonseca K, Hahn C, Selena A, et al. Hemorrhagic encephalopathy associated with COVID-19. J Neuroimmunol. 2020;346:577326. DOI: 10.1016\/j.jneuroim.2020.577326","DOI":"10.1016\/j.jneuroim.2020.577326"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Dixon L, Varley J, Gontsarova A, Mallon D, Tona F, Muir D, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e789. DOI: 10.1212\/NXI.0000000000000789","DOI":"10.1212\/NXI.0000000000000789"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Safaa Saeed Al Mazrouei, Ghufran Aref Saeed, Abeer Ahmed Al Helali, Manzoor Ahmed. COVID-19-associated encephalopathy: neurological manifestation of COVID-19. Radiol Case Rep. 2020;15(9):1646-1649. DOI: 10.1016\/j.radcr.2020.07.009","DOI":"10.1016\/j.radcr.2020.07.009"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Orsucci D, Caldarazzo-Ienco E, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:2020-5-1. DOI: 10.7573\/dic.2020-5-1","DOI":"10.7573\/dic.2020-5-1"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Kilinc D, van de Pasch S, Doets AY, Jacobs BC, van Vliet J, Garssen MPJ. Guillain-Barr\u00e9 syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020;27(9):1757-1758. DOI: 10.1111\/ene.14398.","DOI":"10.1111\/ene.14398"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Dalakas MC. Guillain-Barr\u00e9 syndrome: the first documented COVID-19-triggered autoimmune neurologic disease More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e781. DOI: 10.1212\/NXI.0000000000000781","DOI":"10.1212\/NXI.0000000000000781"}],"container-title":["Revista Alergia M\u00e9xico"],"original-title":[],"link":[{"URL":"https:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/download\/828\/2335","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/download\/828\/1344","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/download\/828\/2335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:52:33Z","timestamp":1744213953000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/view\/828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,1,9]]}},"URL":"https:\/\/doi.org\/10.29262\/ram.v67i4.828","relation":{},"ISSN":["2448-9190","0002-5151"],"issn-type":[{"type":"electronic","value":"2448-9190"},{"type":"print","value":"0002-5151"}],"subject":[],"published":{"date-parts":[[2021,2,13]]}}}